top of page
Publications


🦟 One step closer to a Zika vaccine. New publication by KU Leuven
Prof. Dr. Kai Dallmeier and his team at KU Leuven have published in Nature Communications the preclinical results of YF-ZIK, a chimeric live-attenuated vaccine candidate built on the backbone of the yellow fever vaccine (YF17D), one of the most effective human vaccines ever developed. 📌 Why Zika still matters: In adults, infection is often mild. But in pregnant women, it can be devastating — causing severe congenital defects including microcephaly in newborns. To this day,


New publication by UKER: Yellow Fever Vaccination: How Long-Lived Immune Memory Is Established
Researchers at FAU Erlangen-Nürnberg and Universitätsklinikum Erlangen show that an early metabolic "standby mode" — established in T cells shortly after vaccination — is the key to durable immune protection. The findings could reshape how we design and evaluate vaccines. The yellow fever vaccine (YF17D) is one of the most effective immunizations ever developed. A single dose can provide robust protection lasting decades — possibly a lifetime. Because of the extraordinary du


New Publication by LMU: Interferon-induced activation of dendritic cells and monocytes
Yellow Fever Vaccination: How Strong Immune Responses Are Triggered Researchers show how specific immune cells are activated by the...


New Publication: Baseline Immunity Shapes Yellow Fever Vaccine Response
Our project partners at KUM, IP, and LMU have published a new study examining how the state of our immune system before vaccination...


Publication: Prior flavivirus immunity and the yellow fever vaccine response
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus...
bottom of page
